Novo Nordisk Sues Amneal Over Vagifem Generic
According to Novo — the U.S. unit of Danish drugmaker Novo Nordisk A/S — Bridgewater, N.J.-based Amneal’s plan to make 10 microgram estradiol vaginal tablets infringes on U.S. Patent Number 7,018,992, which covers Vagifem’s method of administration.
“Plaintiffs will be harmed substantially and irreparably if defendants are not enjoined from infringing the ‘992 patent,”...
Already a subscriber? Click here to login